Edwards Lifesciences Corp Stock In The News
| EW Stock | USD 69.29 1.34 1.97% |
Our overall analysis of Edwards Lifesciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Edwards Lifesciences Corp. The specific impact of Edwards Lifesciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Edwards Lifesciences' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Edwards Lifesciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Edwards Lifesciences Backtesting and Edwards Lifesciences Hype Analysis.
Edwards |
Edwards Lifesciences Today Top News and Investor Outlook
Edwards Lifesciences Corp Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Edwards and other traded companies coverage with news coverage. We help investors stay connected with Edwards headlines for the 14th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Edwards Stock performance. Please note that trading solely based on the Edwards Lifesciences Corp hype is not for everyone as timely availability and quick action are needed to avoid losses.
Edwards Lifesciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Edwards earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Edwards Lifesciences that are available to investors today. That information is available publicly through Edwards media outlets and privately through word of mouth or via Edwards internal channels. However, regardless of the origin, that massive amount of Edwards data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Edwards Lifesciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Edwards Lifesciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Edwards Lifesciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Edwards Lifesciences alpha.
Edwards Largest EPS Surprises
Earnings surprises can significantly impact Edwards Lifesciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2012-10-19 | 2012-09-30 | 0.09 | 0.1 | 0.01 | 11 | ||
2012-04-24 | 2012-03-31 | 0.08 | 0.09 | 0.01 | 12 | ||
2011-10-19 | 2011-09-30 | 0.07 | 0.06 | -0.01 | 14 | ||
2010-07-21 | 2010-06-30 | 0.07 | 0.08 | 0.01 | 14 | ||
2009-07-20 | 2009-06-30 | 0.06 | 0.07 | 0.01 | 16 | ||
2009-02-03 | 2008-12-31 | 0.06 | 0.07 | 0.01 | 16 |
Edwards Lifesciences Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Edwards Lifesciences Corp Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
12th of March 2025
Signum Surgical appoints CEO to spearhead BioHealx launch at massdevice.com
11th of March 2025
Dorsey Whitney Trust CO LLC Decreases Holdings in Edwards Lifesciences Co. at thelincolnianonline.com
10th of March 2025
Edwards Lifesciences Corporation Among the Top Stocks to Buy According to Citadel Investme... at insidermonkey.com
7th of March 2025
Disposition of 21910 shares by Bruls Annette of Edwards Lifesciences at 92.85 subject to R... at gurufocus.com
6th of March 2025
Disposition of 5000 shares by Donald Bobo of Edwards Lifesciences at 45.2767 subject to Ru... at thelincolnianonline.com
5th of March 2025
Rosen Law Firm Urges Maravai Lifesciences Holdings, Inc. Stockholders to Contact the Firm ... at businesswire.com
28th of February 2025
Financial Security Advisor Inc. Makes New Investment in Edwards Lifesciences Co. at thelincolnianonline.com
25th of February 2025
Anatara Lifesciences Reports Strong Growth and Progress in GaRP Trial at finnewsnetwork.com.au
21st of February 2025
Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule... at Andrew Dahl
18th of February 2025
Edwards Lifesciences Corp s Winning Formula Financial Metrics and Competitive Strengths at gurufocus.com
29th of January 2025
Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule... at Andrew Dahl
28th of January 2025
Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule... at Andrew Dahl
27th of January 2025
Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule... at Andrew Dahl
24th of January 2025
Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule... at Andrew Dahl
23rd of January 2025
Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule... at Andrew Dahl
22nd of January 2025
Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule... at Andrew Dahl
17th of January 2025
Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule... at Andrew Dahl
10th of January 2025
Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule... at Andrew Dahl
3rd of January 2025
Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule... at Andrew Dahl
31st of December 2024
Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule... at Andrew Dahl
30th of December 2024
Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule... at Andrew Dahl
27th of December 2024
Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule... at Andrew Dahl
24th of December 2024
Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule... at Andrew Dahl
20th of December 2024
Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule... at Andrew Dahl
13th of December 2024
Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule... at Andrew Dahl
Edwards Lifesciences Investors Sentiment
The influence of Edwards Lifesciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Edwards. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Edwards Lifesciences' public news can be used to forecast risks associated with an investment in Edwards. The trend in average sentiment can be used to explain how an investor holding Edwards can time the market purely based on public headlines and social activities around Edwards Lifesciences Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Edwards Lifesciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Edwards Lifesciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Edwards Lifesciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Edwards Lifesciences.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Edwards Lifesciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Edwards Lifesciences' short interest history, or implied volatility extrapolated from Edwards Lifesciences options trading.
Additional Tools for Edwards Stock Analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.